From GlobeNewswire: 2024-05-06 16:05:00

Telesis Bio Inc. announced a 1-for-18 reverse stock split of its common stock to regain compliance with Nasdaq requirements. The split will take effect on May 9, 2024, reducing outstanding shares from 30.1 million to 1.7 million. No fractional shares will be issued, and stockholders will be rounded up to the nearest whole number. Adjustments will be made to warrants, stock options, and equity awards. Telesis Bio is a leading provider of RNA and DNA solutions for therapeutic discovery and will provide more information to stockholders through their transfer agent. Source: Globe Newswire.



Read more at GlobeNewswire: Telesis Bio Announces Reverse Stock Split